8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Melatonin in pathogenesis and therapy of cancer

Bioeffects Seen

Authors not listed · 2006

Share:

EMF exposure may increase cancer risk by disrupting melatonin, your body's natural tumor-fighting hormone.

Plain English Summary

Summary written for general audiences

This 2006 review examined melatonin's role in cancer development and treatment, focusing on the 'melatonin hypothesis' that links nighttime light exposure and electromagnetic fields to increased cancer rates. The researchers found that EMF exposure can disrupt melatonin production, potentially contributing to breast cancer and childhood leukemia through this hormonal pathway.

Why This Matters

This review crystallizes one of the most important mechanisms by which EMF exposure may contribute to cancer: melatonin suppression. The science demonstrates that our pineal gland's melatonin production, which regulates sleep cycles and provides powerful antioxidant protection, can be disrupted by both artificial light at night and electromagnetic fields. What this means for you is that the EMF exposure from your devices isn't just a direct cellular concern - it's also undermining one of your body's most important natural cancer-fighting systems. The melatonin hypothesis helps explain why we're seeing increased cancer rates in our electromagnetically saturated world, particularly breast cancer and childhood leukemia, which correlate with areas of highest EMF exposure.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2006). Melatonin in pathogenesis and therapy of cancer.
Show BibTeX
@article{melatonin_in_pathogenesis_and_therapy_of_cancer_ce1442,
  author = {Unknown},
  title = {Melatonin in pathogenesis and therapy of cancer},
  year = {2006},
  doi = {10.4103/0019-5359.28983},
  
}
DOI: 10.4103/0019-5359.28983PubMed: 17130668

Quick Questions About This Study

The melatonin hypothesis proposes that exposure to artificial light at night and electromagnetic fields increases cancer risk by suppressing melatonin production. This hormone normally provides antioxidant protection and regulates immune function against tumor development.
Breast cancer and childhood leukemia show the strongest associations with melatonin disruption from EMF exposure. The research also identifies connections with melanoma, colon cancer, and lung cancer through altered melatonin patterns.
Electromagnetic fields can disrupt the pineal gland's normal melatonin synthesis patterns, similar to how artificial light suppresses this hormone. This interference with your body's natural circadian rhythm reduces protective antioxidant activity.
Clinical studies show melatonin treatment reduces death risk and adverse effects in cancer patients, suggesting supplementation may help. However, addressing the root cause of EMF-induced melatonin suppression remains the primary prevention strategy.
Melatonin functions as an oncostatic (tumor-inhibiting) agent through its antioxidant properties, free radical scavenging abilities, and immune system modulation. These mechanisms help prevent cancer cell formation and growth naturally.